Botulinum toxin for drooling in Parkinson's disease

Fiona Hill; Nick Miller; Richard A. Walsh; David Mockler; Ronald Mcdowell; Margaret Walshe

doi:10.1002/14651858.CD012408

Botulinum toxin for drooling in Parkinson's disease

Fiona Hill
, Nick Miller
, Richard A. Walsh
, David Mockler
, Ronald Mcdowell
, Margaret Walshe

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.

Original language	English
Article number	CD012408
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD012408
Publication status	Published (in print/issue) - 28 Oct 2016

Bibliographical note

Publisher Copyright:
© 2016 The Cochrane Collaboration.

Access to Document

10.1002/14651858.CD012408

Cite this

@article{363efb52285d49e58251bade97fbb9f4,

title = "Botulinum toxin for drooling in Parkinson's disease",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.",

author = "Fiona Hill and Nick Miller and Walsh, \{Richard A.\} and David Mockler and Ronald Mcdowell and Margaret Walshe",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration.",

year = "2016",

month = oct,

day = "28",

doi = "10.1002/14651858.CD012408",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley \& Sons, Inc.",

number = "10",

}

TY - JOUR

T1 - Botulinum toxin for drooling in Parkinson's disease

AU - Hill, Fiona

AU - Miller, Nick

AU - Walsh, Richard A.

AU - Mockler, David

AU - Mcdowell, Ronald

AU - Walshe, Margaret

PY - 2016/10/28

Y1 - 2016/10/28

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.

UR - https://www.scopus.com/pages/publications/84992530877

U2 - 10.1002/14651858.CD012408

DO - 10.1002/14651858.CD012408

M3 - Article

AN - SCOPUS:84992530877

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD012408

ER -

Botulinum toxin for drooling in Parkinson's disease

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this